HRSA

HRSA Notice 2026-03838

The Health Resources and Services Administration (HRSA) has issued Notice 2026-03838. This notice provides general information and updates relevant to healthcare providers and public health authorities. Specific details regarding the content of the notice are available via the provided URL.

HRSA Announces 340B Rebate Model Pilot Program Application Process

The HRSA announced the application process for a voluntary 340B Rebate Model Pilot Program for qualifying drug manufacturers. The agency is also requesting public comment on the program's structure and application process, with a deadline of September 8, 2025.

HHS Proposed Rule: HIV Organ Transplant Policy Equity Act Implementation

The Department of Health and Human Services (HHS) proposes to amend regulations implementing the National Organ Transplant Act (NOTA) to remove research and Institutional Review Board (IRB) requirements for the transplantation of kidneys and livers from HIV-positive donors to HIV-positive recipients. This proposed rule aligns with the HIV Organ Policy Equity (HOPE) Act.

HOPE Act Final Regulatory Impact Analysis

The Health Resources and Services Administration (HRSA) has published the final Regulatory Impact Analysis (RIA) for the HOPE Act. This document details the anticipated costs and benefits associated with the implementation of the HOPE Act.

HRSA Document HRSA-2026-0001-0001

The Health Resources and Services Administration (HRSA) has issued a new government document, identified as HRSA-2026-0001-0001. This notice serves as an informational update for healthcare providers and public health authorities within the United States.

Maternal, Infant, Early Childhood Home Visiting Program Data Collection

The Health Resources and Services Administration (HRSA) has submitted a request to the Office of Management and Budget (OMB) for continued approval of the Maternal, Infant, and Early Childhood Home Visiting Program Performance Measurement Information System. This revision consolidates data collection forms and aims to reduce administrative burden and align with current guidelines.

Agency Information Collection Activities: Public Comment Request

The Health Resources and Services Administration (HRSA) has submitted a revision to the Ryan White HIV/AIDS Program Part F Dental Services Report for OMB review and approval. A public comment period is open until March 30, 2026.

Public Comment Request for Standardized Work Plan Form

The Health Resources and Services Administration is requesting public comment on a proposed standardized work plan form for use with applications for research and training grants and cooperative agreements. The comment period closes on May 5, 2026.

HRSA Ryan White HIV/AIDS Program Part F Public Comment Request

The Health Resources and Services Administration (HRSA) is requesting public comment on proposed information collection activities related to the HRSA Ryan White HIV/AIDS Program Part F National AIDS Education and Training Center Program. The comment period closes on April 8, 2026.

HRSA Lowers Out-of-Pocket Medication Costs at Health Centers

The Health Resources and Services Administration (HRSA) has issued updated award terms requiring HRSA-funded health centers to provide insulin and injectable epinephrine to low-income patients at or below the price paid by the center through the 340B Drug Pricing Program. This action aims to lower out-of-pocket costs for life-saving medications nationwide.